MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bcp.12997

Медицинская библиотека · British journal of clinical pharmacology · 2016

R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.

Ho Thang, Pollock Bruce G, Mulsant Benoit H, Schantz Oliver, Devanand Devangere P, Mintzer Jacobo E, Porsteinsson Anton P, Schneider Lon S, Weintraub Daniel, Yesavage Jerome, Drye Lea T, Munro Cynthia A, Shade David M, Lyketsos Constantine, Bies Robert

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

AIMS: The aim was to determine the relationship between (R) and (S)-citalopram enantiomer exposure (AUC(0,24 h)) and therapeutic response in agitated individuals greater than 60 years old with Alzheimer's dementia (AD).

METHODS

Citalopram enantiomer exposures (AUC(0,24 h)) derived from an established population pharmacokinetic analysis were utilized to explore the relationship between (R)- and (S)-citalopram area under the curve (AUC(0,24 )) and Mini-Mental State Examination (MMSE), Neurobehavioural Rating Scale-Agitation Subscale (NBRS-A), modified Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (mADCS-CGIC) and Neuropsychiatric Inventory Agitation subscale (NPIA) scores. Time dependent changes in these scores (disease progression) were accounted for prior to exploring the exposure effect relationship for each enantiomer. These relationships were evaluated using a non-linear-mixed effects modelling approach as implemented in nonmem v7.3.

RESULTS

(S)-AUC(0,24 h) and (R)-AUC(0,24 h) each contributed to improvement in NBRS-A scores (k3(R) -0.502; k4(S) -0.712) as did time in treatment. However, increasing (R)-AUC(0,24 h) decreased the probability of patient response (maximum Δ -0.182%/AUC(0,24 h)) based on the CGIC while (S)-AUC(0,24 h) improved the probability of response (maximum Δ 0.112%/AUC(0,24 h)). (R)-AUC(0,24 h) was also associated with worsening in MMSE scores (-0.5 points).

CONCLUSIONS

Our results suggest that citalopram enantiomers contributed differentially to treatment outcomes. (R)-citalopram accounted for a greater proportion of the adverse consequences associated with racemic citalopram treatment in patients with AD including a decreased probability of treatment response as measured by the CGIC and a reduction in MMSE scores. The S-enantiomer was associated with increased probability of response based on the CGIC.

Для цитирования: Ho Thang, Pollock Bruce G, Mulsant Benoit H, Schantz Oliver, Devanand Devangere P, Mintzer Jacobo E, Porsteinsson Anton P, Schneider Lon S, Weintraub Daniel, Yesavage Jerome, Drye Lea T, Munro Cynthia A, Shade David M, Lyketsos Constantine, Bies Robert. R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.. British journal of clinical pharmacology. 2016. DOI: 10.1111/bcp.12997.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.